RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,219,000 | +1.6% | 850,000 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $2,185,000 | +11.8% | 850,000 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $1,955,000 | -28.4% | 850,000 | 0.0% | 0.01% | -20.0% |
Q3 2018 | $2,729,000 | +13.4% | 850,000 | 0.0% | 0.01% | +11.1% |
Q2 2018 | $2,406,000 | -20.0% | 850,000 | 0.0% | 0.01% | -25.0% |
Q1 2018 | $3,009,000 | -8.8% | 850,000 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $3,298,000 | +52.8% | 850,000 | 0.0% | 0.01% | +33.3% |
Q3 2017 | $2,159,000 | -7.0% | 850,000 | 0.0% | 0.01% | -10.0% |
Q2 2017 | $2,321,000 | -17.5% | 850,000 | 0.0% | 0.01% | -16.7% |
Q1 2017 | $2,814,000 | +39.1% | 850,000 | 0.0% | 0.01% | +33.3% |
Q4 2016 | $2,023,000 | -35.2% | 850,000 | 0.0% | 0.01% | -30.8% |
Q3 2016 | $3,120,000 | +154.3% | 850,000 | +54.5% | 0.01% | +116.7% |
Q2 2016 | $1,227,000 | +7.3% | 550,000 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $1,144,000 | -65.7% | 550,000 | -50.0% | 0.01% | -28.6% |
Q4 2015 | $3,334,000 | +145.3% | 1,100,000 | +100.0% | 0.01% | +16.7% |
Q3 2015 | $1,359,000 | – | 550,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |